Keith Bailey, M.D.

Medical Oncologist

Medical School
Louisiana State University Medical Center, New Orleans, LA

Internship/Residency
Southwestern Michigan Area Health Education Center at Borgess and Bronson Hospitals, Kalamazoo, MI

Fellowship
North Carolina Memorial Hospital, University of North Carolina, Chapel Hill, NC

Keith Bailey, M.D.  rejoined WMCC after many years in private practice.  He is board certified in internal medicine and medical oncology.

Dr. Bailey has served as Teaching Attending Physician through Michigan State University / Kalamazoo Center for Medical Studies (MSU/KCMS) at both hospitals in the department of Internal Medicine. Dr. Bailey is a member of the American Society of Clinical Oncology and the Michigan Society of Hematology and Oncology.

Anne Cavanagh, MD

Quality of Life Director

Medical School and Residency
Wayne State University
Detroit, MI

B.S–University of Michigan
Ann Arbor, MI

Anne Cavanagh, MD, leads WMCC’s new Quality of Life program. Dr. Cavanagh works with a team of health care professionals to coordinate specialized medical care for patients in need of relief from pain, fatigue, stress and other difficult cancer side effects.  This extra layer of support comes from doctors, nurses and other specialists and is appropriate at any age or at any stage.  The goal is to improve the quality of life for both the patient and the family.

Board certified in internal medicine and hospice and palliative medicine, Dr. Cavanagh practiced at Bronson Methodist Hospital and Borgess Medical Center for more than 20 years.  Most recently, she served as Bronson’s Medical Director, Palliative Care.  She also cared for patients through Borgess Visiting Nurse and Hospice and was its medical director for two years.   Dr. Cavanagh spent 12 years in academic medicine at Michigan State University Kalamazoo Center for Medical Studies where she was Clinical Director of Internal Medicine.

Sreenivasa R. Chandana, MD, PhD

Medical Oncologist/Hematologist

Medical School
Guntur Medical School
Guntur, India

PhD
Wayne State University School of Medicine
Department of Pharmacology
Detroit, MI

Residency
McLaren Regional Medical Center
Flint, Michigan

Fellowship
Michigan State University
Division of Hematology/Oncology
East Lansing, MI

Sree Chandana, MD, is board certified in internal medicine, medical oncology and hematology. He is widely published and has received numerous awards. His clinical and research interests include gastrointestinal, thoracic, head and neck cancers as well as lymphomas.

Dr. Chandana is an associate of the American Society of Clinical Oncology and the American Society of Hematology.

Glen D. Heggie, M.D.

Medical Oncologist/Hematologist

Medical School
University of Michigan
Ann Arbor, Michigan

Internship and Residency
Kaiser Foundation Hospital
Oakland, California

Fellowship
University of Alabama at Birmingham
Department of Medicine Division of Hematology/Oncology

Glen D. Heggie, M.D., is board certified in internal medicine, hematology, oncology, and geriatrics. He has been in practice for more than 30 years and joined West Michigan Cancer Center in 1994. Prior to joining WMCC, he practiced in Idaho and Alabama.

Dr. Heggie is published and serves on WMCC’s Institutional Review Board. He is a Fellow of the American College of Physicians, and is on the medical staffs of  Borgess and Bronson Hospitals as well as Three Rivers Heath.

Sanja Kaluza, MD MPH

Medical Oncologist

Medical School
Karl Franzens University
Graz, Austria

Residency
University of Arizona
Tucson, AZ

Fellowship
Michigan State University
East Lansing, MI

Sanja Kaluza, MD MPH, joined WMCC after completing a Hematology/Oncology Fellowship at Michigan State University in East Lansing.   Dr. Kaluza is board certified in internal medicine, medical oncology and hematology and she oversees our new Survivorship Clinic.  As Clinic Director, her focus is to develop and implement long term care plans for cancer survivors in collaboration with WMCC social workers, dietitians, genetic counselor and financial counselors.  The Survivorship Clinic team works to address the unique needs of cancer survivors while promoting a healthy lifestyle.  Dr. Kaluza also works with the oncology team and primary care providers to monitor for recurrence in cancer survivors.  She is fluent in several languages—English, German and her native language, Bosnian/Serbian & Croatian.

 

Marcia K. Liepman, M.D.

Medical Oncologist/Hematologist

Medical School
University of Michigan Hospitals
Ann Arbor, Michigan

Internship and Residency
University of Michigan Hospitals
Ann Arbor, Michigan

Hematology Fellowship
University of Michigan Hospitals
Simpson Memorial Institute

Oncology Fellowship
University of Michigan Hospitals
Section of Oncology

Marcia Liepman, M.D., is board certified in oncology and hematology and has practiced for more than 35 years. She joined West Michigan Cancer Center in 1996.

Dr. Liepman is published and lectures frequently. She is on the medical staff at  Borgess and Bronson Hospitals, Lee Memorial Hospital and Allegan General Hospital. Before coming to WMCC, Dr. Liepman served on the staffs of University of Michigan Medical Center and University of Massachusetts Medical Center.

Kirk Payne, M.D.

Medical Oncologist/Hematologist

Medical School, Internship and Residency
Medical College of Virginia
Richmond, Virginia

Hematology/Oncology Fellowship
University of Virginia
Charlottesville, Virginia

Clinical Medical Ethics Fellowship
The University of Chicago
Chicago, Illinois

Bone Marrow Transplantation Fellowship
Fred Hutchinson Cancer Center
Seattle, Washington

Kirk Payne, M.D., is board certified in medical oncology, hematology, and hospice/palliative medicine. Dr. Payne served on the faculties of the University of Iowa and the Medical College of Virginia before entering private practice in 2001. He has special interest in caring for patients with breast, lung and colorectal tumors, and lymphoma.

Muhammad Rafi, MD

Medical Oncologist

Medical School
Intermediate Government College
Jaranwala, Pakistan

Nishtar Medical College
Multan, Pakistan

Internship
Mercy Health Partners
Toledo, OH

Residency
VA Medical Center and Mount Sinai Hospital
Bronx, NY and New York, NY

Muhammad Rafi, MD, is board certified in internal medicine and medical oncology.  Prior to becoming a physician in private practice in Battle Creek and Kalamazoo, he worked in pharmaceutical research at the Upjohn Company.  Dr. Rafi cares for patients with all types of cancers and is a member of medical staffs of Borgess Medical Center and Bronson Methodist Hospital in Kalamazoo.

 

Tolga Tuncer, MD

Director, Neuro Oncology Clinic

 

Medical School
University of Ankara
School of Medicine
Ankara, Turkey

Residency
University of Istanbul
Istanbul, Turkey

Fellowships
Radiation Oncology
Ohio State University
James Cancer Hospital
Columbus, OH

Radiation Oncology
University of Alabama at Birmingham
Birmingham, AL

Neuro Oncology
Barrow Neurological Institute
St. Joseph’s Hospital & Medical Center
Phoenix, AZ

Hematology & Oncology
University of Arizona—Arizona Cancer Center
Tucson, AZ

Born in the US and raised in Ankara, Turkey, Dr. Tuncer has cared for cancer patients for 18 years and is the Director of WMCC’s Neuro Oncology Clinic.  He is board certified in internal medicine and neuro oncology and board eligible in hematology and medical oncology.

Dr. Tuncer’s clinical interests include primary and secondary brain tumors, metastatic central nervous system tumors, lung cancer and cervical cancer.   

Bennett W. Yu, MD

Medical Oncologist and Hematologist, and Director of Research

Medical School
University of Michigan
Ann Arbor, MI

Residency
Albany Medical Center Hospitals, Albany Medical College
Albany, NY

Fellowship-Hematology
University of Virginia
Charlottesville,VA

Fellowship-Medical Oncology
National Cancer Institute and the National Institutes of Health
Bethesda, MD

Bennett Yu, MD, comes to WMCC from Salisbury, Maryland where he served as Director of Oncology Research at the Peninsula Cancer Center at Peninsula Regional Medical Center.   Previously he served as a hematologist/oncologist at Henry Ford Hospital and held faculty positions at Karmanos Cancer Institute, EasternVirginia Medical School, and the Medical Oncology Branch of the NCI.  He also worked in targeted therapy phase I-III drug development at Wyeth Research (now Pfizer).  He has peer-reviewed publications in basic science, translational research and clinical trials.

His clinical interests include care of breast, lung and GI cancer patients.  Dr. Yu is board certified in internal medicine, hematology and medical oncology.  As the Director of Research, he is helping to improve access for patients to cutting edge clinical trials for cancer patients, improving the quality and safety of research.  He is also helping to develop collaborative research projects with faculty at WMCC, Bronson and Borgess Hospitals, the Western Michigan University School of Medicine, and other academic programs.